Crisis communicators give Zuckerberg high marks for testimony

Crisis communicators give Zuckerberg high marks for testimony

The Facebook CEO did not wilt during this week's marathon Senate session.

Facebook share price rebounds after Zuckerberg's testimony

Facebook share price rebounds after Zuckerberg's testimony

Despite the US Congress's lack of insight into Facebook's operations, Mark Zuckerberg's handling of the situation seems to have restored investor confidence in the company.

Interview | Scott Dulitz, TrialCard

Interview | Scott Dulitz, TrialCard

Scott Dulitz, SVP, Corporate Strategy, Business Development for TrialCard, outlines how embracing the modern hub allows brands to reach their full potential.

Johnson & Johnson marketing executive Debra Bass joins Nuvo

Johnson & Johnson marketing executive Debra Bass joins Nuvo

She will lead Nuvo Group's U.S. operations and head marketing globally.

Standing out in the era of value-based healthcare marketing

Standing out in the era of value-based healthcare marketing

With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.

HealthSpark 2018 unites disruptors at SXSW

HealthSpark 2018 unites disruptors at SXSW

AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed

Infographic | AI's impact on patients and caregivers

Infographic | AI's impact on patients and caregivers

Caregivers and patients predict how the use of AI will affect them.

Cannes Lions names new chairman

Cannes Lions names new chairman

Philip Thomas takes over from Terry Savage.

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.

MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.

What is a digital medicine, exactly? Akili co-founder Adam Gazzaley explains

What is a digital medicine, exactly? Akili co-founder Adam Gazzaley explains

MM&M spoke with Gazzaley about what's next for Akili, how he defines "digital medicine," and where the field is currently positioned on the hype cycle.

Rise of the health-tech ethicist

Rise of the health-tech ethicist

Want to get an ethicist agitated? Mention the integration of voice-activation and other tech into healthcare. Experts say navigating this area is a work in progress.

SXSW: Tech empathy, data skepticism, and a Black Eyed Pea fuel health track's surge

SXSW: Tech empathy, data skepticism, and a Black Eyed Pea fuel health track's surge

Health's popularity at SXSW continues to build. Here's our opening weekend wrap-up.

Pharma CMO: Why We're Being Blinded by Our Brands

Pharma CMO: Why We're Being Blinded by Our Brands

Recently, Forbes ran an article from Wild Pixel Media founder and CEO Carlos Machicao lamenting the fact that healthcare advertising is boring.